spacer
spacer

PDBsum entry 4ht1

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
4ht1

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
131 a.a.
210 a.a.
217 a.a.
Waters ×100
PDB id:
4ht1
Name: Immune system
Title: Human tweak in complex with the fab fragment of a neutralizing antibody
Structure: Tumor necrosis factor ligand superfamily member 12. Chain: t. Synonym: apo3 ligand, tnf-related weak inducer of apoptosis, tweak, tumor necrosis factor ligand superfamily member 12, membrane form, tumor necrosis factor ligand superfamily member 12, secreted form. Chimeric antibody fab. Chain: h. Chimeric antibody fab. Chain: l
Source: Homo sapiens. Human. Organism_taxid: 9606. Oryctolagus cuniculus. Organism_taxid: 9986. Other_details: chimeric antibody. Other_details: chimeric antibody
Resolution:
2.50Å     R-factor:   0.188     R-free:   0.211
Authors: A.Lammens
Key ref: A.Lammens et al. (2013). Crystal structure of human TWEAK in complex with the Fab fragment of a neutralizing antibody reveals insights into receptor binding. Plos One, 8, e62697. PubMed id: 23667509 DOI: 10.1371/journal.pone.0062697
Date:
31-Oct-12     Release date:   12-Jun-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O43508  (TNF12_HUMAN) -  Tumor necrosis factor ligand superfamily member 12 from Homo sapiens
Seq:
Struc:
249 a.a.
131 a.a.
Protein chain
No UniProt id for this chain
Struc: 210 a.a.
Protein chain
No UniProt id for this chain
Struc: 217 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1371/journal.pone.0062697 Plos One 8:e62697 (2013)
PubMed id: 23667509  
 
 
Crystal structure of human TWEAK in complex with the Fab fragment of a neutralizing antibody reveals insights into receptor binding.
A.Lammens, M.Baehner, U.Kohnert, J.Niewoehner, L.von Proff, M.Schraeml, K.Lammens, K.P.Hopfner.
 
  ABSTRACT  
 
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine playing a key role in tissue regeneration and remodeling. Dysregulation of TWEAK signaling is involved in various pathological processes like autoimmune diseases and cancer. The unique interaction with its cognate receptor Fn14 makes both ligand and receptor promising targets for novel therapeutics. To gain insights into this important signaling pathway, we determined the structure of soluble human TWEAK in complex with the Fab fragment of an antibody selected for inhibition of receptor binding. In the crystallized complex TWEAK is bound by three Fab fragments of the neutralizing antibody. Homology modeling shows that Fab binding overlaps with the putative Fn14 binding site of TWEAK. Docking of the Fn14 cysteine rich domain (CRD) to that site generates a highly complementary interface with perfectly opposing charged and hydrophobic residues. Taken together the presented structure provides new insights into the biology of TWEAK and the TWEAK/Fn14 pathway, which will help to optimize the therapeutic strategy for treatment of related cancer types and autoimmune diseases.
 

 

spacer

spacer